PNC Financial Services Group’s Summit Therapeutics SMMT Stock Holding History

PNC Financial Services Group’s Portfolio SMMT Stock Details SMMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.36K	Sell	299 -944	-76%	-$16.7K	﹤0.01%	4441
2026 Q1	$23.6K	Buy	1,243 +754	+154%	+$12.2K	﹤0.01%	3616
2025 Q4	$8.55K	Sell	489 -1,301	-73%	-$24.5K	﹤0.01%	4029
2025 Q3	$37K	Sell	1,790 -848	-32%	-$20.6K	﹤0.01%	3356
2025 Q2	$56.1K	Buy	2,638 +2,018	+325%	+$46K	﹤0.01%	3045
2025 Q1	$12K	Buy	620 +100	+19%	+$2.01K	﹤0.01%	3762
2024 Q4	$9.28K	Buy	520 +50	+11%	+$969	﹤0.01%	3829
2024 Q3	$10.3K	Buy	470 +425	+944%	+$5.94K	﹤0.01%	3789
2024 Q2	$351	Buy	+45	New	+$243	﹤0.01%	4583
2021 Q4	–	Sell	-2,000	Closed	-$10K	–	4600
2021 Q3	$10K	Buy	2,000 +1,000	+100%	+$7.18K	﹤0.01%	3758
2021 Q2	$7K	Buy	+1,000	New	+$6.56K	﹤0.01%	3803

Other funds holding SMMT

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

PNC Financial Services Group's SMMT Position: Q2 2026 in Review

PNC Financial Services Group reduced its Summit Therapeutics (SMMT) stake by 76% in Q2 2026, selling an estimated $16.7K and leaving 299 shares worth $4.36K. The position accounts for ﹤0.01% of the portfolio, ranked #4441.

PNC Financial Services Group first reported a position in SMMT in Q2 2021 and has held it in 11 quarters since. The position peaked at $56.1K in Q2 2025. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

PNC Financial Services Group held 299 shares of Summit Therapeutics worth $4.36K as of Q2 2026.
PNC Financial Services Group sold 944 Summit Therapeutics shares in Q2 2026, an estimated $16.7K.
Summit Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4441 holding.
PNC Financial Services Group first reported a position in Summit Therapeutics in Q2 2021 and has held it in 11 quarters since.
PNC Financial Services Group's Summit Therapeutics position peaked at $56.1K in Q2 2025.
242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.